193 related articles for article (PubMed ID: 37895229)
21. Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.
Hu YH; Zhou L; Wang SS; Jing X; Guo HL; Sun F; Zhang Y; Chen F; Xu J; Ji X
Curr Pharm Des; 2019; 25(6):627-634. PubMed ID: 30931851
[TBL] [Abstract][Full Text] [Related]
22. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
23. VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.
Toosi B; Zaker F; Alikarami F; Kazemi A; Teremmahi Ardestanii M
Biomed Pharmacother; 2018 Jun; 102():428-437. PubMed ID: 29574283
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.
Kordes U; Krappmann D; Heissmeyer V; Ludwig WD; Scheidereit C
Leukemia; 2000 Mar; 14(3):399-402. PubMed ID: 10720133
[TBL] [Abstract][Full Text] [Related]
25. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB.
Bastian L; Hof J; Pfau M; Fichtner I; Eckert C; Henze G; Prada J; von Stackelberg A; Seeger K; Shalapour S
Clin Cancer Res; 2013 Mar; 19(6):1445-57. PubMed ID: 23357978
[TBL] [Abstract][Full Text] [Related]
26. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
27. Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
Munzert G; Kirchner D; Ottmann O; Bergmann L; Schmid RM
Leuk Lymphoma; 2004 Jun; 45(6):1181-4. PubMed ID: 15359998
[TBL] [Abstract][Full Text] [Related]
28. Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
Hegge IR; Kaspers GJ; Rots MG; Jansen G; Pieters R; Veerman AJ
Adv Exp Med Biol; 1999; 457():551-5. PubMed ID: 10500833
[TBL] [Abstract][Full Text] [Related]
29. Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia.
Chen YL; Tang C; Zhang MY; Huang WL; Xu Y; Sun HY; Yang F; Song LL; Wang H; Mu LL; Li MH; Zheng WW; Miao Y; Ding LX; Li BS; Shen SH; Liu SL; Li H; Zhu ZQ; Chen HW; Tang ZH; Chen J; Hong DL; Chen HZ; Duan CW; Zhou BS
Leukemia; 2019 Oct; 33(10):2365-2378. PubMed ID: 30940905
[TBL] [Abstract][Full Text] [Related]
30. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
[TBL] [Abstract][Full Text] [Related]
32. β-catenin promotes MTX resistance of leukemia cells by down-regulating FPGS expression via NF-κB.
Liu SG; Yue ZX; Li ZG; Zhang RD; Zheng HY; Zhao XX; Gao C
Cancer Cell Int; 2020; 20():271. PubMed ID: 32587478
[TBL] [Abstract][Full Text] [Related]
33. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha -supported proliferation of leukemia and lymphoma cell lines.
Liu RY; Fan C; Liu G; Olashaw NE; Zuckerman KS
J Biol Chem; 2000 Jul; 275(28):21086-93. PubMed ID: 10783388
[TBL] [Abstract][Full Text] [Related]
34. Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines.
Canevarolo RR; Melo CPS; Cury NM; Artico LL; Corrêa JR; Tonhasca Lau Y; Mariano SS; Sudalagunta PR; Brandalise SR; Zeri ACM; Yunes JA
Front Oncol; 2022; 12():1032336. PubMed ID: 36531023
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
36. The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.
Woźniak M; Makuch S; Pastuch-Gawołek G; Wiśniewski J; Szeja W; Nowak M; Krawczyk M; Agrawal S
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925555
[TBL] [Abstract][Full Text] [Related]
37. Th1 cytokines in pediatric acute lymphoblastic leukemia.
Schober S; Rottenberger JM; Hilz J; Schmid E; Ebinger M; Feuchtinger T; Handgretinger R; Lang P; Queudeville M
Cancer Immunol Immunother; 2023 Nov; 72(11):3621-3634. PubMed ID: 37610672
[TBL] [Abstract][Full Text] [Related]
38. Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.
Mehrpouri M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M; Bashash D
Eur J Pharmacol; 2020 May; 875():173050. PubMed ID: 32142770
[TBL] [Abstract][Full Text] [Related]
39. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations.
Göker E; Waltham M; Kheradpour A; Trippett T; Mazumdar M; Elisseyeff Y; Schnieders B; Steinherz P; Tan C; Berman E
Blood; 1995 Jul; 86(2):677-84. PubMed ID: 7605998
[TBL] [Abstract][Full Text] [Related]
40. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
Thyss A; Suciu S; Bertrand Y; Mazingue F; Robert A; Vilmer E; Mechinaud F; Benoit Y; Brock P; Ferster A; Lutz P; Boutard P; Marguerite G; Plouvier E; Michel G; Plantaz D; Munzer M; Rialland X; Chantraine JM; Norton L; Solbu G; Philippe N; Otten J
J Clin Oncol; 1997 May; 15(5):1824-30. PubMed ID: 9164191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
